This is the first study to exhibit the anti-tumor effects of PYR on OSCC in vitro and in vivo, and demonstrated PYR inhibited OSCC cells by inducing apoptosis via the PI3K/ AKT and MAPK pathway. The gene discussed is AKT1; the disease is neoplasm.